10-Q: Q3 2024 Earnings Report

SECNov 14 05:37 · Announcements

Pasithea Therapeutics Priced $5M Private Placement of $1.2M Shares At $4.10/Share to Advance Next-Gen Cancer Treatments

BenzingaSep 27 15:03

Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswireSep 27 06:44

Express News | Pasithea Therapeutics Announces $5 Million Private Placement Priced at-the-Market Under Nasdaq Rules

BreakingsSep 27 06:44

Express News | Pasithea Therapeutics Corp - No Treatment-Related Adverse Events or Dose-Limiting Toxicities Observed

BreakingsSep 26 19:02

Express News | Pasithea Therapeutics Corp - Patient With Stage 3 Colon Cancer Achieves Prolonged Stable Disease

BreakingsSep 26 19:02